Skip to main content

Find Clinical Trials

Home
Conditions
Hepatitis B, Chronic

Clinical trial condition

Hepatitis B, Chronic

Explore clinical trials studying Hepatitis B, Chronic. Study availability and eligibility vary by location and protocol.

532 public trials 70 recruiting studies

Refine in advanced search Browse all conditions

Hepatitis B, Chronic trial results

Completed

Telbivudine Versus Adefovir Dipivoxil in Adults With HBegAg-Positive, Compensated Chronic Hepatitis B

NCT00115245

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations: Los Angeles, California, United States

Pasadena, California, United States

San Francisco, California, United States

Miami, Florida, United States

View all 15 locations

View Trial Details

Completed

A Randomized, Double Blind Trial of LdT (Telbivudine) Versus Lamivudine in Adults With Compensated Chronic Hepatitis B

NCT00057265

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations: Los Angeles, California, United States

Orange, California, United States

San Diego, California, United States

Hackensack, New Jersey, United States

View Trial Details

Completed

Viral Kinetics Study of Telbivudine and Entecavir in Adults With Chronic Hepatitis B

NCT00412529

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations: Holy Family Hospital_Bucheon Bucheon,Kyunggi, South Korea

Inje University Busan Paik Hospital Busan, South Korea

Yeungnam University Medical Center Daegu, South Korea

Gachon Univ. Gil Medical Center Hospital Incheon, South Korea

View Trial Details

Completed

HBsAg Clearance in Inactive Chronic HBsAg Carriers After Interferon Treated

NCT01471535

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations: liver disease center, Beijing Ditan Hospital Beijing, Beijing Municipality, China

View Trial Details

Completed

Continuing Lamivudine Versus Switching to Entecavir in Patients Who Achieved Undetectable Hepatitis B Virus DNA

NCT00637663

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Pusan National University School of Medicine Busan, South Korea

Severance Hospital Seoul, South Korea

View Trial Details

Completed

Phase II Trial for Combination Treatment of PEG-Tα1 and Adefovir for HBeAg Positive Chronic Hepatitis B

NCT02366208

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: 302 Military Hoapital of China Beijing, Beijing Municipality, China

Hainan General Hospital Haikou, Hainan, China

The Third Hospital of Hebei Medical University Shijiazhuang, Hebei, China

The Second Xiangya Hospital of Central South University Changsha, Hunan, China

View Trial Details

Completed

Tenofovir in Asian Chronic Hepatitis B Patients

NCT01728935

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations: Department of Medicine, The University of Hong Kong, Queen Mary Hospital Hong Kong

View Trial Details

Completed

An Open Study to Evaluate the Efficacy, Safety of Clevudine Monotherapy or Adefovir and Clevudine Combination in Patients With Chronic Hepatitis B

NCT01264354

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations: Samsung Medical Center Seoul, South Korea

View Trial Details

Completed

A Study to Evaluate the Efficacy and Safety of Clevudine and Peg-interferon in Sequence Compared With Clevudine Alone in the Patients With HBeAg(+) Chronic Hepatitis B or Clevudine and Peg-interferon Sequential Treatment in Patients With Chronic Hepatitis B Who Have HBeAg(+)

NCT01264367

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +15 more
Locations: Uijeongbu St.Mary's Hospital Uijeongbu-si, South Korea

View Trial Details

Completed

Efficacy and Safety Study of Entecavir Plus Tenofovir in Patients With Chronic Hepatitis B Who Failed Previous Treatment

NCT01063036

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations: Local Institution Clichy, France

Local Institution Lyon, France

Local Institution Orléans, France

Local Institution Strasbourg, France

View all 28 locations

View Trial Details